GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 355 filers reported holding GUARDANT HEALTH INC in Q1 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,846,291 | -17.2% | 500,887 | 0.0% | 0.31% | -8.2% |
| Q2 2023 | $17,931,755 | +77.5% | 500,887 | +16.2% | 0.34% | +62.4% |
| Q1 2023 | $10,099,991 | -13.8% | 430,887 | 0.0% | 0.21% | -12.1% |
| Q4 2022 | $11,720,126 | -70.0% | 430,887 | -40.6% | 0.24% | -73.5% |
| Q3 2022 | $39,074,000 | +4.7% | 725,887 | -21.5% | 0.90% | -6.5% |
| Q2 2022 | $37,310,000 | -18.4% | 924,887 | +34.1% | 0.96% | +1.9% |
| Q1 2022 | $45,698,000 | -43.8% | 689,887 | -15.2% | 0.95% | -20.4% |
| Q4 2021 | $81,350,000 | -29.7% | 813,342 | -12.1% | 1.19% | -31.9% |
| Q3 2021 | $115,677,000 | +1.4% | 925,342 | +0.8% | 1.74% | +1.4% |
| Q2 2021 | $114,038,000 | +22.5% | 918,253 | +50.6% | 1.72% | +18.4% |
| Q1 2021 | $93,082,000 | +24.1% | 609,774 | +4.8% | 1.45% | +15.5% |
| Q4 2020 | $75,004,000 | +42.9% | 581,970 | +24.0% | 1.26% | -0.5% |
| Q3 2020 | $52,480,000 | – | 469,498 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |